Australia vs Paraguay: Previously treated cases tested for RR-/MDR-TB
Australia
76.0%
in 2024
Paraguay
75.0%
in 2024
Australia rank
120th
Paraguay rank
123rd
Previously treated cases tested for RR-/MDR-TB over time
- Australia
- Paraguay
How they compare
Australia currently reports 76.0% against 75.0% in Paraguay, a difference of 1.0%.
The two have swapped places 4 times across 15 shared years of data; in 2010 it was Australia ahead.
Australia ranks 120th and Paraguay ranks 123rd of 180 countries.
Across the 2 decades both report, Australia averaged higher in 1 and Paraguay in 1.
Head to head by decade
| Decade | Australia | Paraguay | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 72.0% | 43.8% | 28.2% | Australia |
| 2020s | 73.2% | 83.8% | 10.6% | Paraguay |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Australia or Paraguay?
- Australia, at 76.0% against 75.0% in Paraguay as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Australia and Paraguay?
- 1.0%, with Australia ahead.
- How many years of comparable data are there for Australia and Paraguay?
- 15 years are reported by both, from 2010 to 2024.
- How do Australia and Paraguay rank globally for previously treated cases tested for rr-/mdr-tb?
- Australia ranks 120th and Paraguay ranks 123rd of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.